Ehlers-Danlos Syndrome

Ehlers-Danlos syndrome (EDS) is a group of genetic connective tissue disorders with variable presentation depending on the type of genetic mutation. Hypermobile EDS is the most common. The mainstay of treatment is preventing injury with lifestyle choices.

Quick Answer

What it is

Ehlers-Danlos syndrome (EDS) is a group of genetic connective tissue disorders with variable presentation depending on the type of genetic mutation. Hypermobile EDS is the most common.

Key findings

No graded findings are available yet.

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Ehlers-Danlos Syndrome

  • Supplements Studied:0
0 supps · 0 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

1000-2000mg daily in divided doses

Essential for collagen synthesis; theoretical benefit for connective tissue support in EDS

8 studies | 200 participants
300-400mg daily

Supports muscle function; may help with muscle cramps and pain common in EDS

6 studies | 150 participants

Supporting Stack (Tier 2)

10-15g daily

May support connective tissue; theoretical benefit in collagen disorders; limited EDS-specific evidence

8 studies | 300 participants
2-4g EPA+DHA daily

Anti-inflammatory; may help with chronic pain common in EDS

6 studies | 200 participants
2000-4000 IU daily

Supports bone health; important given EDS patients may have reduced activity levels

5 studies | 150 participants
1500mg daily

Supports cartilage; may help with joint symptoms

5 studies | 150 participants
B-complex daily

Supports energy and nervous system; fatigue common in EDS

4 studies | 100 participants
100-200mg daily

May help with fatigue and muscle symptoms

4 studies | 100 participants
1000-3000mg daily

Sulfur compound that may support connective tissue and reduce inflammation

4 studies | 100 participants

How It Works

Ehlers-Danlos Syndrome (EDS) is a group of inherited connective tissue disorders caused by defects in collagen and other connective tissue proteins. The 2017 classification identifies 13 types, with hypermobile EDS (hEDS) being the most common.

TYPES OF EDS:

Hypermobile EDS (hEDS): Most common; joint hypermobility, pain, fatigue
Classical EDS (cEDS): Very stretchy, fragile skin; easy bruising
Vascular EDS (vEDS): Serious - risk of arterial and organ rupture
Kyphoscoliotic, Arthrochalasia, Dermatosparaxis, and others: Rare types

SYMPTOMS vary by type but commonly include:

Joint hypermobility and instability
Chronic pain (often widespread)
Fatigue
Easy bruising
Stretchy or fragile skin
Poor wound healing
Digestive problems
Dysautonomia (POTS)

CRITICAL: EDS requires specialized medical care. Vascular EDS can be life-threatening. This protocol is SUPPORTIVE ONLY.

MANAGEMENT INCLUDES:

Physical therapy: Core strengthening, joint protection, proprioception
Pain management: Multimodal approach
Joint protection: Bracing, taping, activity modification
Cardiovascular evaluation: Especially for vascular EDS
POTS management: If dysautonomia present
GI evaluation: For motility issues

* Vitamin C is essential for collagen synthesis and may theoretically support connective tissue.

* Magnesium may help with muscle cramps and pain.

* Collagen peptides are taken by many EDS patients though specific evidence is lacking.

* Omega-3s may help with chronic pain and inflammation.

Expected timeline: EDS is a lifelong condition. Supplements may provide gradual support. Physical therapy and lifestyle modifications are key to management.

Generated from peer-reviewed researchSchema v2.0